An Early Phase II Study of Oral S-1, a Newly Developed 5-Fluorouracil Derivative for Advanced and Recurrent Gastrointestinal Cancers
Year: 1999
Type: article
Study design: Clinical Trial
Source: Oncology
DOI: 10.1159/000012032
Authors: Keizo Sugimachi, Yoshihiko Maehara, Noboru Horikoshi, Yosuhiro Shimada, Yuh Sakata, Yasushi Mitachi, Tetsuo Taguchi
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: S-1, oral fluoropyrimidine, 5-fluorouracil derivatives, 1-(2-tetrahydrofuryl)-5-fluorouracil, advanced gastric cancer, recurrent gastric cancer, colorectal cancer, advanced colorectal cancer, potassium oxonate, dihydropyrimidine dehydrogenase, gastrointestinal toxicity, anticancer activity, response rate
Open Access status: closed
Funder: Taiho Pharmaceutical
OpenAlex ID: W2027678619
